WATSON 460 (Glipizide 5 mg)

Pill imprint WATSON 460 has been identified as Glipizide 5 mg.

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 460

Glipizide 5 mg WATSON 460
Glipizide 5 mg WATSON 460  Front
Glipizide 5 mg WATSON 460  Back
Glipizide 5 mg WATSON 460
Glipizide 5 mg WATSON 460
Glipizide
Imprint:
WATSON 460
Strength:
5 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Sulfonylureas
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-0460
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
lactose anhydrous
microcrystalline cellulose
corn starch
stearic acid
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0116 McKesson Packaging Services
54569-3841 A S Medication Solutions LLC (repackager)
49999-0108 Lake Erie Medical and Surgical Supply (repackager)
63874-0316 Altura Pharmaceuticals Inc (repackager)
58016-0876 Southwood Pharmaceuticals Inc (repackager)
55289-0806 PDRX Pharmaceuticals Inc (repackager)
53002-0446 Pharmedix (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)